Arrowstreet Capital, Limited Partnership Vericel Corp Transaction History

Arrowstreet Capital, Limited Partnership

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$14.68 - $19.12 $2.07 Million - $2.69 Million	-140,892 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$8.5 - $15.82 $1.2 Million - $2.23 Million	140,892 New	140,892 $1.95 Million
Q1 2020 May 15, 2020	SELL	$7.25 - $19.22 $851,208 - $2.26 Million	-117,408 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$13.77 - $19.2 $1.62 Million - $2.25 Million	117,408 New	117,408 $2.04 Million
Q2 2019 Aug 14, 2019	SELL	$15.01 - $18.89 $156,104 - $196,456	-10,400 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$16.23 - $20.29 $168,792 - $211,016	10,400 New	10,400 $182,000
Q4 2018 Feb 14, 2019	SELL	$10.77 - $18.44 $752,166 - $1.29 Million	-69,839 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$9.1 - $14.8 $69,160 - $112,480	7,600 Added 12.21%	69,839 $988,000
Q2 2018 Aug 14, 2018	BUY	$9.6 - $14.6 $597,494 - $908,689	62,239 New	62,239 $604,000

276

48.4M

91.8K

23.2K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.79B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.